MediSapiens, Bayer Developing Platform for Cancer Genomic Data Analysis | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MediSapiens today announced that it and Bayer HealthCare Pharmaceuticals have reached an agreement to develop a platform for the analysis of cancer genomics data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.